NCT07115459

Brief Summary

This study aims to develop and validate a prognostic model for neurocritical patients using multimodal brain monitoring data. By combining data from various monitoring techniques such as EEG, TCD, and NIRS, this model will help predict 90-day outcomes (awake, comatose, or deceased) and support personalized treatment decisions. The study is observational and involves no experimental interventions.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
15mo left

Started Jan 2024

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress69%
Jan 2024Dec 2027

Study Start

First participant enrolled

January 8, 2024

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

August 3, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

August 11, 2025

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2027

Last Updated

September 17, 2026

Status Verified

September 1, 2026

Enrollment Period

3 years

First QC Date

August 3, 2025

Last Update Submit

September 14, 2026

Conditions

Keywords

Multimodal Brain MonitoringPrognostic Model

Outcome Measures

Primary Outcomes (1)

  • 90-day Outcome Prediction

    The primary outcome is the prediction of patient status at 90 days post-ICU admission, categorized as awake, comatose, or deceased.

    90-day

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Neurocritical patients aged 18-80 years with acute brain injury admitted to the ICU.

You may qualify if:

  • Aged 18-80 years, no gender restrictions.
  • Diagnosed with acute brain injury (ABI), including one of the following: large cerebral infarction, supratentorial large-volume intracerebral hemorrhage, subarachnoid hemorrhage, or severe traumatic brain injury, with imaging evidence (CT or MRI) supporting the diagnosis.
  • On ICU admission, Glasgow Coma Scale (GCS) eye response = 1 (no eye opening) and motor score ≤ 5 (does not follow commands); or within 48 hours, neurological deterioration with no eye opening and motor score reduced to ≤ 5 (total GCS score ≤ 8).
  • Able to undergo continuous multimodal monitoring, with an expected ICU stay of ≥72 hours.
  • Informed consent signed by the family or legal representative.

You may not qualify if:

  • Confirmed brain death on admission or imaging showing irreversible brain herniation.
  • Severe trauma unrelated to brain injury (e.g., multiple fractures, spinal cord injuries, or visceral rupture) that may interfere with brain function monitoring or outcome assessment.
  • Pre-existing severe neurological disorders such as epilepsy, severe encephalopathy, or chronic intracranial conditions (e.g., brain tumors or hydrocephalus).
  • Inability to perform multimodal monitoring due to technical issues (e.g., equipment failure or sensor installation problems).
  • Predicted survival time \<24 hours after admission, or family members choose to withdraw treatment.
  • Refusal to participate in the study by the patient or their legal representative.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

XiangyaHospital of Central South University

Changsha, Hunan, 410080, China

RECRUITING

MeSH Terms

Conditions

Cerebral InfarctionIntracranial HemorrhagesSubarachnoid HemorrhageBrain Injuries, Traumatic

Condition Hierarchy (Ancestors)

Brain InfarctionBrain IschemiaCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesStrokeVascular DiseasesCardiovascular DiseasesInfarctionIschemiaPathologic ProcessesPathological Conditions, Signs and SymptomsNecrosisHemorrhageBrain InjuriesCraniocerebral TraumaTrauma, Nervous SystemWounds and Injuries

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 3, 2025

First Posted

August 11, 2025

Study Start

January 8, 2024

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2027

Last Updated

September 17, 2026

Record last verified: 2026-09

Data Sharing

IPD Sharing
Will not share

There is no plan to share individual participant data (IPD) due to privacy, ethical, or regulatory considerations

Locations